Results 61 to 70 of about 22,899 (254)
Physico-chemical requirements and kinetics of membrane fusion of flavivirus-like particles. [PDF]
, 2015 Flaviviruses deliver their RNA genome into the host-cell cytoplasm by fusing their lipid envelope with a cellular membrane. Expression of the flavivirus pre-membrane and envelope glycoprotein genes in the absence of other viral genes results in the ...
core +1 more source
The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker [PDF]
, 2013 The flavivirus nonstructural glycoprotein NS1 is an enigmatic protein whose structure and mechanistic function have remained somewhat elusive ever since it was first reported in 1970 as a viral antigen circulating in the sera of dengue-infected patients.
Muller, David A., Young, Paul R.
core +1 more source
Microbiology and Immunology, EarlyView.ABSTRACT Orthobornaviruses express X and the phosphoprotein (P) from a bicistronic X/P mRNA, and these proteins regulate polymerase activity. In mammalian orthobornaviruses, the 5′ untranslated region (5′ UTR) of the X/P mRNA controls the translational balance between X and P and thereby promotes efficient replication.
Meng‐Chi Wu +7 more
wiley +1 more source
Human Vaccines & Immunotherapeutics, 2013 Japanese encephalitis (JE) is an infectious disease of the central nervous system caused by Japanese encephalitis virus (JEV), a zoonotic mosquito-borne flavivirus. JEV is prevalent in much of Asia and the Western Pacific, with over 4 billion people living at risk of infection.
Yun, Sang-Im, Lee, Young-Min
openaire +2 more sources
DharmaJapanese Encephalitis (JE) is an infectious disease of the central nervous system caused by the Japanese Encephalitis Virus (JEV), JEV is the main cause of viral encephalitis in Asia. This virus is transmitted by mosquitoes and is zoonotic.
Siti Naimah, Jennifa Jennifa
doaj +1 more source
Canadian Journal of Infectious Diseases and Medical Microbiology, 2019 The attenuated Japanese encephalitis virus (JEV) live vaccine SA14-14-2 prepared from wild-type (WT) strain SA14 was licensed to prevent Japanese encephalitis (JE) in 1989 in China.
Rong Huang +5 more
doaj +1 more source
The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries. [PDF]
, 2018 With social policies increasingly directed toward enhancing equity through health programs, it is important that methods for estimating the health and economic benefits of these programs by subpopulation be developed, to assess both equity concerns and ...
Brenzel, Logan +16 more
core +2 more sources
Acta Paediatrica, EarlyView.ABSTRACT The incidence of Tick‐borne encephalitis (TBE) cases has increased. The presumed location of transmission of Tick‐borne encephalitis virus (TBEV) has been expanding increasingly in the western parts of Europe during the past decade. There has also been an increased incidence of surveillance‐reported TBE cases in southern Sweden and southern ...
H. H. Askling, D. Zavadska
wiley +1 more source
Vaccines for preventing Japanese encephalitis [PDF]
Cochrane Database of Systematic Reviews, 2003 Vaccination is recognized as the only practical measure for preventing Japanese encephalitis. Production shortage, costs, and issues of licensure impair vaccination programmes in many affected countries. Concerns over vaccine effectiveness and safety also have a negative impact on acceptance and uptake.To evaluate vaccines for preventing Japanese ...
Schiøler, Karin Linda +2 more
openaire +3 more sources
Epidemiology of Japanese encephalitis in the Philippines: a systematic review.
PLoS Neglected Tropical Diseases, 2015 BackgroundJapanese encephalitis virus (JEV) is an important cause of encephalitis in most of Asia, with high case fatality rates and often significant neurologic sequelae among survivors. The epidemiology of JE in the Philippines is not well defined.
Anna Lena Lopez +9 more
doaj +1 more source